Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of pazopanib hydrochloride for advanced thyroid cancer shows results post-completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Pazopanib hydrochloride (pazopanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Thyroid Gland Carcinoma, Stage III Differentiated Thyroid Gland Carcinoma AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2020-02-26